Cartesian Therapeutics, Inc.: cash_and_equivalents
| Value | {"amount": 58228000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2018-03-31) |
| Status | current |
| Entity | Cartesian Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:22:00.935149+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/d4b81965-11a6-4e06-905e-7cbb5138e8fc
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001453687-18-000030Retrieved: 2026-08-19T14:22:00.935149+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001453687/cash-and-equivalents/2018-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/d4b81965-11a6-4e06-905e-7cbb5138e8fc
History
- no predecessors — first report